Fatal infections in childhood leukemia.
D000293:Adolescent; D000380:Agranulocytosis; D002175:Candida / Q000302:isolation & purification; D002648:Child; D002675:Child, Preschool; D004761:Enterocolitis, Pseudomembranous / Q000150:complications / Q000401:mortality; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D007223:Infant; D007239:Infections / Q000150:complications* / Q000401:mortality; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009181:Mycoses / Q000150:complications; D011014:Pneumonia / Q000150:complications / Q000401:mortality; D011241:Prednisone / Q000627:therapeutic use; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012075:Remission, Spontaneous; D018805:Sepsis / Q000150:complications / Q000401:mortality; D013210:Staphylococcus / Q000302:isolation & purification; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate